GB Sciences, Inc.
GBLX · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $6 | $9 | $18 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $2 | $1 | $1 | $4 |
| Enterprise Value | $4 | $8 | $10 | $21 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$4 | -$1 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.012 | -0.002 | -0.012 |
| % Growth | 64.3% | -576.5% | 85.5% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$2 |